Skip to main content

Key role identified for enzymes in DNA replication and sensitivity to chemotherapeutic drugs

Media mentions
10 Aug 18



Group Leader
Tel.+34 93 40 31183


Communication Officer
Tel.+34 93 40 37255

Catalunya Press, Revista Genética, among other national and international media, have published articles about a study co-led by Travis H. Stracker, head of the Genomic Instability and Cancer Lab, which has identified a key role for enzymes in DNA replication and sensitivity to chemotherapeutic drugs.

Link to Catalunya Press

Link to Revista Genética

Link to Medindia


About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 28 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).